← Open Payments lookup

KIRSTEN MANGANIELLO: Open Payments

NPI 1104259050 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$987 in 45 payments from 17 companies in 2025. Trend: 2023 $449 · 2024 $762 · 2025 $987

Food & beverage: $987
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$225
Novo Nordisk Inc6$108
GlaxoSmithKline, LLC.5$95
ABBVIE INC.4$94
SHIELD THERAPEUTICS INC4$81
Amgen Inc.4$79
Insulet Corporation2$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$28
Verona Pharma, Inc.1$27

Products named: AIRSUPRA, ACCRUFER, TRELEGY ELLIPTA, Omnipod, CAPLYTA, VRAYLAR, OTEZLA, BREZTRI.

Industry payments across NY — which companies pay providers there.